InvestorsHub Logo

lorbas95

05/01/19 10:17 AM

#40263 RE: ohm20 #40262

You might be right, but it seems that in 9/10 cases companies underestimate the costs and difficulties of a drug launch. But if we count 30m for a successful launch plus 2.5m every month til approval it'll get hard and TNBC and GvHD trials might be pushed back further. I think that we need 50m-60m altogether for the next 9-10 months.